GB201317373D0 - Treatment and prevention of cancer - Google Patents

Treatment and prevention of cancer

Info

Publication number
GB201317373D0
GB201317373D0 GBGB1317373.7A GB201317373A GB201317373D0 GB 201317373 D0 GB201317373 D0 GB 201317373D0 GB 201317373 A GB201317373 A GB 201317373A GB 201317373 D0 GB201317373 D0 GB 201317373D0
Authority
GB
United Kingdom
Prior art keywords
cancer
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1317373.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB1317373.7A priority Critical patent/GB201317373D0/en
Publication of GB201317373D0 publication Critical patent/GB201317373D0/en
Priority to PCT/GB2014/052955 priority patent/WO2015049507A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB1317373.7A 2013-10-01 2013-10-01 Treatment and prevention of cancer Ceased GB201317373D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1317373.7A GB201317373D0 (en) 2013-10-01 2013-10-01 Treatment and prevention of cancer
PCT/GB2014/052955 WO2015049507A1 (en) 2013-10-01 2014-09-30 Treatment and prevention of cancer with aldosterone antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1317373.7A GB201317373D0 (en) 2013-10-01 2013-10-01 Treatment and prevention of cancer

Publications (1)

Publication Number Publication Date
GB201317373D0 true GB201317373D0 (en) 2013-11-13

Family

ID=49585128

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1317373.7A Ceased GB201317373D0 (en) 2013-10-01 2013-10-01 Treatment and prevention of cancer

Country Status (2)

Country Link
GB (1) GB201317373D0 (en)
WO (1) WO2015049507A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1655819A (en) 2002-05-17 2005-08-17 诺瓦提斯公司 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
CN1175879C (en) 2002-06-27 2004-11-17 潘明继 Medicine for curing pain syndrome of late cancer and its preparation
CA2726734C (en) * 2007-06-06 2014-10-07 University Of Maryland, Baltimore Hdac inhibitor ms-275 and aromatase inhibitors for the treatment of cancer
US20100035853A1 (en) 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity
CA2773615A1 (en) 2009-09-11 2011-03-17 Arwed Cleve Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs

Also Published As

Publication number Publication date
WO2015049507A1 (en) 2015-04-09

Similar Documents

Publication Publication Date Title
IL273090B (en) Methods and compositions for the treatment of cancer
ZA201602380B (en) Cancer treatment with combination of plinabulin and taxane
HUE042081T2 (en) Pharmaceutical composition for treatment and/or prevention of cancer
GB201320723D0 (en) Composition and methods of treatment
SG11201508223YA (en) Treatment of cancer with dihydropyrazino-pyrazines
ZA201507733B (en) Treatment of cancer with dihydropyrazino-pyrazines
PL3060211T3 (en) Treatment of cancer and benign proliferative disorders
EP2962693A4 (en) Pharmaceutical composition for prevention and/or treatment of cancer
GB201607581D0 (en) Treatment of cancer
HK1232118A1 (en) Treatment of cancer
HK1220396A1 (en) Treatment and prevention of acne
GB201309431D0 (en) Treatment and prevention of malaria
GB201317373D0 (en) Treatment and prevention of cancer
GB201322346D0 (en) Combination treatment of cancer
HK1214502A1 (en) Combination of ro5503781 and capecitabine for cancer therapy ro5503781
GB201322347D0 (en) Treatment of cancer
GB201318742D0 (en) Treatment of cancer
GB201301685D0 (en) Diagnosis and treatment of cancer
GB201308529D0 (en) Treatment of cancer
TWI561255B (en) Use of umirolimus and its derivatives for treating cancer
GB201305020D0 (en) Treatment of cancer
SG10201802995SA (en) Cancer treatment with combination of plinabulin and taxane
GB201303115D0 (en) Detection and treatment of liver cancer
GB201322958D0 (en) Uses of oligouronates in cancer treatment
GB201202081D0 (en) Prevention and/or treatment of cancer and/or cancer metastasis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)